Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

22
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
22
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.4K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

4.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.3K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.2K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.6K
The pathophysiology of pneumonia involves the following steps:
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants.

JAMA network open·2026
Same author

Derivation and validation of clinical prediction models for viral etiologies of acute diarrhea in North American children presenting for emergency care.

medRxiv : the preprint server for health sciences·2026
Same author

Energy, flow and pressure in the cardiovascular system: a narrative review of how the circulation works.

Anaesthesia·2026
Same author

Initial vaccination platform against S. pneumoniae shapes antibody profiles upon revaccination with pneumococcal conjugate vaccine in older adults.

Cell reports·2026
Same author

Utility of a Multiplex Molecular Respiratory Pathogen Panel on Clinical Management of Children in the Pediatric Emergency Department.

The Journal of molecular diagnostics : JMD·2026
Same author

Association between Weather Variables and Viral Gastroenteritis in the United States.

medRxiv : the preprint server for health sciences·2026
Same journal

Influenza Vaccine Effectiveness Against Pediatric Death in the United States: 2016-2025.

Pediatrics·2026
Same journal

Averting the Unthinkable: Immunization to Prevent Childhood Deaths From Influenza.

Pediatrics·2026
Same journal

Severe Postoperative Hypernatremia in an Adolescent Following Sleeve Gastrectomy.

Pediatrics·2026
Same journal

Barriers to Implementing SMART for Asthma in Pediatric Primary Care.

Pediatrics·2026
Same journal

Blood Lead Testing Among Children Enrolled in Medicaid.

Pediatrics·2026
Same journal

From Screening to Support: Crafting Social Needs Response Systems That Work for Families.

Pediatrics·2026
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K

Pneumococcal Pneumonia in Hospitalized Children: 2017-2023.

Eric E Engstrom1, Sheldon L Kaplan1, William J Barson2

  • 1Texas Children's Hospital and Baylor College of Medicine, Houston, Texas.

Pediatrics
|April 26, 2026
PubMed
Summary
This summary is machine-generated.

COVID-19 pandemic altered pediatric pneumococcal pneumonia trends. Serotype 3 increased post-2020, linked to severe outcomes, while resistance was mainly from serotype 19A.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.9K
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

1.8K

Related Experiment Videos

Last Updated: Apr 28, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.9K
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

1.8K

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Microbiology

Background:

  • Streptococcus pneumoniae is a leading cause of childhood pneumonia.
  • The COVID-19 pandemic may have influenced the epidemiology of pneumococcal pneumonia.

Purpose of the Study:

  • To investigate changes in pediatric Streptococcus pneumoniae pneumonia before, during, and after the COVID-19 pandemic.
  • To analyze variations in clinical presentation, serotypes, and antibiotic susceptibility.

Main Methods:

  • Retrospective analysis of 190 pediatric patients with culture-positive pneumonia from 2017-2023 across 8 US children's hospitals.
  • Serotyping of pneumococcal isolates and collection of clinical and laboratory data.

Main Results:

  • Pneumococcal pneumonia cases decreased in 2020, surging in 2022-2023. Serotype 3 became most common post-2021, associated with higher rates of empyema and necrotizing pneumonia.
  • PCV13 serotypes remained dominant, but PCV15 and PCV20 serotypes comprised 14% and 22% of isolates, respectively. Penicillin susceptibility was high (94%), with resistance linked to serotype 19A.
  • Influenza coinfection was associated with increased pneumonia complications.

Conclusions:

  • Streptococcus pneumoniae continues to cause severe pediatric pneumonia.
  • Post-2020 increases are linked to serotype 3, and β-lactam resistance to serotype 19A.
  • Pneumococcal conjugate vaccines PCV15 and PCV20 may further decrease incidence.